Duronio V, Jacobs S, Romero P A, Herscovics A
Department of Molecular Biology, Burroughs Wellcome Co., Research Triangle Park, North Carolina 27709.
J Biol Chem. 1988 Apr 15;263(11):5436-45.
We have used specific inhibitors of oligosaccharide processing enzymes as probes to determine the involvement of oligosaccharide residues in the biosynthesis and function of insulin and insulin-like growth factor-I receptors. In a previous study (Duronio, V., Jacobs, S., and Cuatrecasas, P. (1986) J. Biol. Chem. 261, 970-975) swainsonine was used to inhibit mannosidase II, resulting in the production of receptors containing only hybrid-type oligosaccharides. These receptors had a slightly lower molecular weight and were much more sensitive to endoglycosidase H, but otherwise behaved identically to normal receptors. In this study, we used two compounds that inhibit oligosaccharide processing at earlier steps: (i) N-methyl-1-deoxynojirimycin (MedJN), which inhibits glucosidases I and II and yields glucosylated, high mannose oligosaccharides, and (ii) manno-1-deoxynojirimycin (MandJN), which inhibits mannosidase I and yields high mannose oligosaccharides. In the presence of MandJN, HepG2 cells synthesized receptors of lower molecular weight, which were cleaved into alpha and beta subunits and were able to bind hormone and autophosphorylate. These receptors were as sensitive to endoglycosidase H as receptors made in the presence of swainsonine. In the presence of MedJN, receptors of only slightly lower molecular weight than normal were synthesized and were shown to contain some glucosylated high mannose oligosaccharides. These receptors were able to bind hormone and retained hormone-sensitive autophosphorylation activity. In both cases, the incompletely processed receptors could be detected at the cell surface by cross-linking of iodinated hormone and susceptibility to trypsin digestion, although less receptor was present in cells treated with MedJN. Studies of receptor synthesis using pulse-chase labeling showed that the receptor precursors synthesized in the presence of MedJN were cleaved into alpha and beta subunits at a slower rate than normal receptors or those made in the presence of MandJN. Inhibition of oligosaccharide processing had no effect on the association of the receptor subunits into disulfide-linked oligomeric complexes.
我们使用寡糖加工酶的特异性抑制剂作为探针,以确定寡糖残基在胰岛素和胰岛素样生长因子-I受体的生物合成及功能中的作用。在之前的一项研究中(Duronio, V., Jacobs, S., and Cuatrecasas, P. (1986) J. Biol. Chem. 261, 970 - 975),苦马豆素被用于抑制甘露糖苷酶II,从而产生仅含有杂合型寡糖的受体。这些受体的分子量略低,对内切糖苷酶H更为敏感,但在其他方面与正常受体表现相同。在本研究中,我们使用了两种在早期步骤抑制寡糖加工的化合物:(i)N-甲基-1-脱氧野尻霉素(MedJN),它抑制葡糖苷酶I和II并产生糖基化的高甘露糖寡糖;(ii)甘露-1-脱氧野尻霉素(MandJN),它抑制甘露糖苷酶I并产生高甘露糖寡糖。在MandJN存在的情况下,HepG2细胞合成了分子量较低的受体,这些受体被切割成α和β亚基,并且能够结合激素并进行自身磷酸化。这些受体对内切糖苷酶H的敏感性与在苦马豆素存在下产生的受体相同。在MedJN存在的情况下,合成的受体分子量仅略低于正常受体,并显示含有一些糖基化的高甘露糖寡糖。这些受体能够结合激素并保留激素敏感的自身磷酸化活性。在这两种情况下,通过碘化激素的交联和对胰蛋白酶消化的敏感性,可以在细胞表面检测到加工不完全的受体,尽管用MedJN处理的细胞中存在的受体较少。使用脉冲追踪标记对受体合成的研究表明,在MedJN存在下合成的受体前体切割成α和β亚基的速度比正常受体或在MandJN存在下产生的受体慢。寡糖加工的抑制对受体亚基形成二硫键连接的寡聚复合物没有影响。